Ligand Pharma (LGND) PT Raised to $144 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $295.47 +0.30%
Rating Summary:
15 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
15 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis raised the price target on Ligand Pharma (NASDAQ: LGND) to $144.00 (from $135.00) while maintaining a Buy rating.
You May Also Be Interested In
- Leerink Starts Ligand Pharma (LGND) at Outperform
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
- Info Edge India (INFOE:IN) PT Raised to INR1,260 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
